Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast Cancer
Phase 2
- Conditions
- Metastatic Breast Cancer
- First Posted Date
- 2005-11-08
- Last Posted Date
- 2005-11-08
- Lead Sponsor
- Zeneus Pharma
- Target Recruit Count
- 45
- Registration Number
- NCT00250874
- Locations
- 🇮🇹
Ospedale Pietrantoni, Forli, Italy
Open Label, Single Arm, Phase II Study Using R-COMP in Elderly Patients With Aggressive NHL.
Phase 2
- Conditions
- Aggressive Non-Hodgkin's Lymphoma in the Elderly.
- First Posted Date
- 2005-10-25
- Last Posted Date
- 2005-10-28
- Lead Sponsor
- Zeneus Pharma
- Target Recruit Count
- 75
- Registration Number
- NCT00244127
- Locations
- 🇮🇹
Universita Degli Studi Di Modena AZ Ospedaliere Policlinico, Modena, Italy
News
No news found